Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative Review

For decades, topical corticosteroids have been the mainstay of treatment for mild-to-moderate inflammatory skin diseases, even though only short-term use is approved for these agents and systemic inflammation is not addressed. Increased understanding of the immunopathogenesis of these conditions, es...

Descripción completa

Detalles Bibliográficos
Autores principales: Blauvelt, Andrew, Langley, Richard G., Gordon, Kenneth B., Silverberg, Jonathan I., Eyerich, Kilian, Sommer, Morten O. A., Felding, Jakob, Warren, Richard B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689637/
https://www.ncbi.nlm.nih.gov/pubmed/37924462
http://dx.doi.org/10.1007/s13555-023-01054-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689637/
https://www.ncbi.nlm.nih.gov/pubmed/37924462
http://dx.doi.org/10.1007/s13555-023-01054-3

Ejemplares similares